ERBB2 and breast cancer: Kim and collaborators showed that the expression of the Human Epidermal growth factor Receptor 2 (HER2) is associated with an higher resistance to radiotherapy in HER2-positive breast cancers compared to other molecular subtypes of breast cancer (74).